Troponin T-SS, a variant of the troponin T protein, plays a crucial role within the troponin complex, integral to the regulation of skeletal and cardiac muscle contraction. Troponin T, along with troponin I and troponin C, forms a complex that binds to tropomyosin, anchoring the troponin complex to the thin filament of the muscle fibers. This interaction is pivotal for the regulation of calcium-mediated muscle contraction. In the resting state, the troponin complex stabilizes tropomyosin over the actin binding sites, preventing actin-myosin interaction and thus muscle contraction. Upon activation, troponin T undergoes conformational changes that are essential for the contractile process, facilitating the movement of tropomyosin away from the actin binding sites and allowing for the cross-bridge cycling that leads to muscle contraction. The function of troponin T within this complex underscores its importance in the precise control of muscle contractions, critical for both heart function and skeletal muscle activity.
The activation of Troponin T-SS, and the troponin complex as a whole, is intricately linked to calcium ions (Ca2+). The increase in intracellular Ca2+ levels during muscle excitation triggers the binding of Ca2+ to troponin C, initiating a series of conformational changes within the troponin complex. These changes result in the release of troponin I from actin, allowing troponin T to facilitate the movement of tropomyosin, thereby exposing the actin binding sites to myosin. This finely tuned process is regulated by the precise timing and localization of Ca2+ signals, which are in turn controlled by the cellular mechanisms governing Ca2+ release and reuptake. Moreover, the phosphorylation of troponin T by specific kinases can also modulate its function, affecting the sensitivity of the troponin complex to Ca2+ and thereby fine-tuning muscle contraction. This level of regulation is essential for the diverse range of muscle contractions, from the rapid, forceful contractions of the heart to the varied contractions of skeletal muscles during different types of physical activity. Understanding the activation mechanisms of Troponin T-SS provides critical insights into the molecular basis of muscle contraction and its regulation, highlighting the complex interplay of structural and biochemical factors that enable muscle function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases intracellular cAMP levels, potentially enhancing protein kinase A (PKA) activity, which can phosphorylate proteins in the cardiac muscle, indirectly affecting TNNT1 activity in regulating muscle contraction. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A beta-adrenergic agonist that can stimulate cAMP production, potentially leading to the activation of PKA. PKA activation can result in the phosphorylation of cardiac muscle proteins, indirectly influencing TNNT1 function. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Known to increase intracellular calcium levels and enhance muscle contraction. It could indirectly influence TNNT1 activity by affecting calcium handling in muscle cells. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Stimulates beta-adrenergic receptors, increasing cAMP and PKA activity, which could indirectly influence TNNT1 by modifying the phosphorylation state of proteins involved in muscle contraction. | ||||||
Theophylline | 58-55-9 | sc-202835 sc-202835A sc-202835B | 5 g 25 g 100 g | $20.00 $32.00 $85.00 | 6 | |
Increases cAMP levels by inhibiting phosphodiesterase, potentially affecting TNNT1 activity indirectly through enhanced PKA activity and subsequent phosphorylation of cardiac muscle proteins. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
A calcium channel blocker that can influence calcium signaling in muscle cells. Alterations in calcium signaling can indirectly affect TNNT1's role in muscle contraction. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Another calcium channel blocker, altering calcium dynamics in cardiac muscle cells, potentially influencing TNNT1 activity indirectly through changes in calcium-dependent muscle contraction processes. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
Calcium channel blocker, affecting calcium handling in muscle cells, potentially influencing TNNT1 activity in regulating muscle contraction indirectly. | ||||||
12β-Hydroxydigitoxin | 20830-75-5 | sc-213604 sc-213604A | 1 g 5 g | $143.00 $694.00 | ||
Influences cardiac muscle contractility, potentially affecting TNNT1 activity indirectly through alterations in calcium handling and muscle contraction dynamics. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $165.00 $697.00 | 7 | |
A phosphodiesterase inhibitor that increases cAMP, potentially affecting TNNT1 indirectly by altering PKA activity and the phosphorylation state of proteins involved in muscle contraction. | ||||||